Matter Bio Receives Investment From LifeSpan Vision Ventures
Summary
Matter Bio, a NYC-based longevity holding company focused on preserving genome integrity, received an investment from LifeSpan Vision Ventures. The company intends to use the funds to initiate clinical trials for one of its programs in the next 12 months, as well as scale-up an already revenue generating program in the single molecule mutation sequencing space. co-founded with world-class scientists, including George Church PhD. and Jan Vijg PhD., and led by Chris Bradley, CEO, Matter Bio is a holding company that is advancing multiple scientific results each targeting a critical juncture of information loss. To date, Matter Bio has three companies under its management, with other opportunities in incubation.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected